{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:13:01Z","timestamp":1788509581527,"version":"build-2803163510"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82120108013, 81901652, 81801607"],"award-info":[{"award-number":["82120108013, 81901652, 81801607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Primary biliary cholangitis (PBC), an organ-specific autoimmune disease, is characterized by injury to small bile ducts, inflammatory cell infiltrates within the liver, progressive cholestasis, and in some cases, cirrhosis with unclear pathogenesis. We aimed to clarify the importance role of hepatic immunce cells in the pathogenesis of human and experimental PBC.The dominant-negative TGF\u03b2 receptor type II transgenic (dnTGF\u03b2RII) mice, a well-studied and established murine model of PBC were used to identify changes of immune cells, especially the pathogenic CD8<jats:sup>+<\/jats:sup> T cells. The high-throughput single-cell RNA sequencing technology were applied and found functional heterogeneity among the hepatic CD8<jats:sup>+<\/jats:sup> T cells subsets in dnTGF\u03b2RII mice. CD8<jats:sup>+<\/jats:sup> T cells were confirmed the key cells leading to the pathogenesis of PBC in dnTGF\u03b2RII mice, and identified the terminally differentiated CD8\u03b1\u03b1 T cells and CD8\u03b1\u03b2 T cell subsets in the liver of dnTGF\u03b2RII mice. While terminally differentiated CD8\u03b1\u03b1 T cells have higher cytokine production ability and cytotoxicity, the terminally differentiated CD8\u03b1\u03b2 T cells retain their proliferative profile. Our work suggests that there are developmental and differentiated trajectories of pathogenic CD8<jats:sup>+<\/jats:sup> T cell subsets in the pathogenesis of PBC. A further clarification of their roles would be helpful to our understanding of the pathogenesis of PBC and may potentially lead to identifying novel therapeutic modalities.<\/jats:p>","DOI":"10.3389\/fimmu.2022.860311","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T06:10:07Z","timestamp":1650435007000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yichen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Hua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin Liver Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary Biliary Cholangitis: Pathogenesis and Therapeutic Opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastro Hepat"},{"key":"B3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary Biliary Cholangitis: 2018 Practice Guidance From the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i7.926","article-title":"Primary Biliary Cirrhosis: Pathophysiology, Clinical Presentation and Therapy","volume":"7","author":"Purohit","year":"2015","journal-title":"World J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29053","article-title":"Primary Biliary Cholangitis: Treatment Options Finally Expand","volume":"65","author":"Levy","year":"2017","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary Biliary Cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and Management of Primary Biliary Cholangitis","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI14698","article-title":"Quantitative and Functional Analysis of Pdc-E2-Specific Autoreactive Cytotoxic T Lymphocytes in Primary Biliary Cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180315","article-title":"Distribution of B Lymphocytes in Nonsuppurative Cholangitis in Primary Biliary Cirrhosis","volume":"18","author":"Nakanuma","year":"1993","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02367.x","article-title":"Significance of Periductal Langerhans Cells and Biliary Epithelial Cell-Derived Macrophage Inflammatory Protein-3alpha in the Pathogenesis of Primary Biliary Cirrhosis","volume":"31","author":"Harada","year":"2011","journal-title":"Liver Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.04.001","article-title":"Increased Killing Activity and Decreased Cytokine Production in Nk Cells in Patients With Primary Biliary Cirrhosis","volume":"26","author":"Chuang","year":"2006","journal-title":"J Autoimmun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0199-z","article-title":"Liver-Resident Nk Cells Suppress Autoimmune Cholangitis and Limit the Proliferation of Cd4(+) T Cells","volume":"17","author":"Zhao","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-015-0381-2","article-title":"Elevated Circulating Cd14(Low)Cd16(+) Monocyte Subset in Primary Biliary Cirrhosis Correlates With Liver Injury and Promotes Th1 Polarization","volume":"16","author":"Peng","year":"2016","journal-title":"Clin Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2559.1994.tb00599.x","article-title":"Quantitative Analysis of Macrophages and Perisinusoidal Cells in Primary Biliary Cirrhosis","volume":"25","author":"Mathew","year":"1994","journal-title":"Histopathology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08778-6","article-title":"Animal Models of Autoimmune Liver Diseases: A Comprehensive Review","volume":"58","author":"Liu","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Anti-Mitochondrial Antibodies and Primary Biliary Cirrhosis in Tgf-Beta Receptor Ii Dominant-Negative Mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22226","article-title":"Adoptive Transfer of Cd8(+) T Cells From Transforming Growth Factor Beta Receptor Type Ii (Dominant Negative Form) Induces Autoimmune Cholangitis in Mice","volume":"47","author":"Yang","year":"2008","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaut.2016.12.012","article-title":"Chemokine Receptor Cxcr3 Deficiency Exacerbates Murine Autoimmune Cholangitis by Promoting Pathogenic Cd8(+) T Cell Activation","volume":"78","author":"Ma","year":"2017","journal-title":"J Autoimmun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.034","article-title":"Murine Autoimmune Cholangitis Requires Two Hits: Cytotoxic Klrg1(+) Cd8 Effector Cells and Defective T Regulatory Cells","volume":"50","author":"Huang","year":"2014","journal-title":"J Autoimmun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21123","article-title":"Liver-Targeted and Peripheral Blood Alterations of Regulatory T Cells in Primary Biliary Cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711980","article-title":"Characterization of Organ-Specific Regulatory B Cells Using Single-Cell Rna Sequencing","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1136","article-title":"Cd8\u03b1\u03b1 Memory Effector T Cells Descend Directly From Clonally Expanded Cd8\u03b1+\u03b2high Tcr\u03b1\u03b2 T Cells In Vivo","volume":"100","author":"Konno","year":"2002","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2019.04.005","article-title":"Therapeutic Trials of Biologics in Primary Biliary Cholangitis: An Open Label Study of Abatacept and Review of the Literature","volume":"101","author":"Bowlus","year":"2019","journal-title":"J Autoimmun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.007","article-title":"Diversity in T Cell Memory: An Embarrassment of Riches","volume":"31","author":"Jameson","year":"2009","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102645","article-title":"Low-Dose Interleukin-2: Biology and Therapeutic Prospects in Rheumatoid Arthritis","volume":"19","author":"Wu","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00712-w","article-title":"The Two Faces of Il-2: A Key Driver of Cd8(+) T-Cell Exhaustion","volume":"18","author":"Kwon","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-017-0002-5","article-title":"Targeting Il-2: An Unexpected Effect in Treating Immunological Diseases","volume":"3","author":"Ye","year":"2018","journal-title":"Signal Transduct Tar"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.078","article-title":"Human Tissue-Resident Memory T Cells are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites","volume":"20","author":"Kumar","year":"2017","journal-title":"Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14752","article-title":"Emperipolesis Mediated by Cd8(+) T Cells Correlates With Biliary Epithelia Cell Injury in Primary Biliary Cholangitis","volume":"24","author":"Zhao","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.05.030","article-title":"Liver Infiltrating T Cells Regulate Bile Acid Metabolism in Experimental Cholangitis","volume":"71","author":"Glaser","year":"2019","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01619","article-title":"Imbalance of the Cd226\/Tigit Immune Checkpoint is Involved in the Pathogenesis of Primary Biliary Cholangitis","volume":"11","author":"Deng","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.860311\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T06:10:10Z","timestamp":1650435010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.860311\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2022.860311"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.860311","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"article-number":"860311"}}